Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of IBS
3.2.1.2 Advancements in treatment options
3.2.1.3 Growing awareness and diagnosis rates
3.2.1.4 Favorable reimbursement policies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects of medications
3.2.2.2 Alternative therapies and home remedies
3.3 Growth potential analysis
3.4 Brand analysis
3.4.1 Ironwood pharmaceuticals, Inc.
3.4.2 Bausch health
3.4.3 Astellas pharma, Inc.
3.4.4 Takeda pharmaceutical company limited
3.4.5 Sebela pharmaceuticals Inc.
3.4.6 Ardelyx
3.5 Regulatory landscape
3.6 Pipeline analysis
3.7 Reimbursement scenario
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Condition, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 IBS-D
5.3 IBS-C
5.4 IBS-M
Chapter 6 Market Estimates and Forecast, By Drug Class, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Antidiarrheals
6.3 Laxatives
6.4 Secretagogues/Prosecretory agents
6.5 Antispasmodics
6.6 Antibiotics
6.7 Retainagogues
6.8 Antidepressants/Neuromodulators
6.9 Other drug classes
Chapter 7 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Tablet
7.3 Liquid
7.4 Powder
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Brick & mortar
8.3 E-commerce
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Ardelyx
10.2 Astellas Pharma, Inc.
10.3 Bausch Health
10.4 Bayer
10.5 Ironwood Pharmaceuticals, Inc.
10.6 Johnson & Johnson
10.7 Sanofi
10.8 Sebela Pharmaceuticals Inc.
10.9 Takeda Pharmaceutical Company Limited
10.10 Validus Pharmaceuticals LLC
